Deepika Singh

Mrs. Deepika Singh


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DSDeepika Singh
Deepika Singh
MSManvendra Singh
Manvendra Singh
EYEkta Yadav
Ekta Yadav
NWNeha Ronald William
Neha Ronald William
DDDeependra Singh Dangi
Deependra Singh Dangi
AVAmita Verma
Amita Verma
Hepatic cancer is well known, and leading cancer around the world and remain asymptomatic diseases. Carissa carandas possess anti-proliferative, antioxidant, hepatoprotective property and used in hepatic cancer. The current study deals to evaluate the chemoprotective and therapeutic property of Carissa carandas embedded silver nanoparticles (CCAgNPs) against diethylnitrosamine (DEN) -induced hepatic cancer. Wistar rats were divided into six groups and hepatic cancer was induced with diethylnitrosamine at the dose of 200 mg/kg BW. The animals were gastrogavaged with standard drug and CCAgNPs for 16 weeks. Serum biomarkers, haematological profile, antioxidants enzymes, inflammatory markers and membrane bound enzymes were assessed to find the anti-proliferative potential of silver nanoparticles. Histological evaluation and microscopic characterizations were also performed to authenticate the outcomes of the present work. Biosynthesized CCAgNPs significantly down-regulated the serum marker enzymes of hepatic and non-hepatic parameter, elevated the levels of enzymatic and non-enzymatic antioxidant profile, elevation in membrane bound enzymes and diminish the levels of inflammatory markers (IL-6, TNF-α, and IL-1β) via NF-κB pathway. Histopathological features also showed recovery of a hepatic architecture in cancer-induced rats in a dose-dependent manner. Our consequences established that such plant mediated silver nanoparticles shown a defensive impact against DEN-induced hepatocarcinogenesis, and serves as a better option to ameliorate the clinical results against hepatocellular carcinoma.

15 September 2018 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
DSDeepika Singh
Deepika Singh
EYEkta Yadav
Ekta Yadav
NWNeha Ronald William
Neha Ronald William
VKVikas Kumar
Vikas Kumar
MSManvendra Singh
Manvendra Singh
AVAmita Verma
Amita Verma